Unbiased AI-powered news
Rescue dogs from multiple countries assisted search efforts in collapsed buildings along Venezuela's northern coast. Venezuelan officials reported 3,535 deaths and more than 18,000 people left homeless nearly two weeks after the June 24 quakes.
globalnews.caRescue dogs from 18 countries joined Venezuelan teams in locating survivors and recovering bodies from rubble after two earthquakes struck the northern coast on June 24. Search operations continued through July 6. Officials said 3,535 people were confirmed dead and 16,740 injured. More than 18,000 remained without homes.
Animal rescues documented Teams recovered pets and stray animals from collapsed structures. In La Guaira, firefighters found a parrot named Panchito alive after nine days under debris. Rescuers from Mexico and El Salvador extracted a dog named Milo from an apartment building after 12 days.
Another dog, Giselle, was pulled from a collapsed building in Caraballeda. The Caracas Fire Department removed a puppy from rubble and provided it water immediately. The department later took the animal into its care.
International teams honored Acting Venezuelan President Delcy Rodriguez presented medals to rescuers and their dogs during a July 4 ceremony. Teams came from Bolivia, Chile, Colombia, Costa Rica, Cuba, the Czech Republic, the Dominican Republic, El Salvador, Germany, Jordan, Lithuania, Mexico, Panama, Portugal, Slovakia, Spain, Turkey and Vietnam.
Rodriguez thanked the teams for their work and said their efforts would be remembered by Venezuelans.
Single source — no framing comparison available.
dailywire.comThe Food and Drug Administration approved enlicitide, sold as Lipfendra, a once-daily oral drug that inhibits PCSK9. The medication will be available in a few weeks at a list price of $315 for a 30-day supply.
indianexpress.comEli Lilly will pay $2.8 billion in cash to acquire AtaiBeckley, a developer of psychedelic treatments for mental health conditions. The deal includes up to $1 billion in additional milestone payments. It adds the target’s compounds to Lilly’s neuroscience programs.
news.ycombinator.comKalshi will allow bets on selected clinical trial results and full FDA decisions, starting with Phase 3 studies from established companies. The FDA separately approved Merck's Lipfendra cholesterol pill based on studies showing up to 60% LDL reduction.